Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature-Reference-Cited by-同舟云学术

Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature

Published:2023-04-20 Issue: Volume:18 Page:
ISSN:1758-3764
Container-title:European Cardiology Review
language:en
Short-container-title:Eur Cardiol

Author:

Giordani Andrea Silvio¹,Baritussio Anna¹,Vicenzetto Cristina¹,Peloso-Cattini Maria Grazia¹,Pontara Elena¹,Bison Elisa¹,Fraccaro Chiara¹,Basso Cristina²,Iliceto Sabino¹,Marcolongo Renzo¹,Caforio Alida Linda Patrizia¹

Affiliation:

1. Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua and Azienda Ospedale Università di Padova, Padua, Italy

2. Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua and Azienda Ospedale Università di Padova, Padua, Italy

Abstract

Fulminant myocarditis, rather than being a distinct form of myocarditis, is instead a peculiar clinical presentation of the disease. The definition of fulminant myocarditis has varied greatly in the last 20 years, leading to conflicting reports on prognosis and treatment strategies, mainly because of varied inclusion criteria in different studies. The main conclusion of this review is that fulminant myocarditis may be due to different histotypes and aetiologies that can be diagnosed only by endomyocardial biopsy and managed by aetiology-directed treatment. This life-threatening presentation requires rapid, targeted management both in the short term (mechanical circulatory support, inotropic and antiarrhythmic treatment and endomyocardial biopsy) and in the long term (including prolonged follow-up). Fulminant presentation has also recently been identified as a risk factor for worsened prognosis, even long after the resolution of the acute phase of myocarditis.

Publisher

Radcliffe Media Media Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference80 articles.

1. Lieberman EB, Hutchins GM, Herskowitz A, et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617–26. https://doi.org/10.1016/0735-1097(91)90493-s; PMID: 1960305.

2. Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: characteristics, treatment, and outcomes. Anatol J Cardiol 2018;19:279–86. https://doi.org/10.14744/AnatolJCardiol.2017.8170; PMID: 29537977.

3. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–5. https://doi.org/10.1056/NEJM200003093421003; PMID: 10706898.

4. Ammirati E, Cipriani M, Lilliu M, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 2017;136:529–45. https://doi.org/10.1161/CIRCULATIONAHA.117.026386; PMID: 28576783.

5. Ammirati E, Veronese G, Brambatti M, et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2019;74:299–311. https://doi.org/10.1016/j.jacc.2019.04.063; PMID: 31319912.